SCHEMBL29793554

SCHEMBL29793554

O=[N+]([O-])c1cc(OC2CCCCO2)ccc1Br

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
WNK1 Q9H4A3 2/20 0.39
HSD11B1 P28845 1/20 0.37
TP53 P04637 1/20 0.36
DHFR P00374 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ALDH1A1 P00352 3/20 0.35
CYP2D6 P10635 1/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
GSTP1 P09211 1/20 0.35
GSTM2 P28161 1/20 0.35
MAPT P10636 4/20 0.35
GAA P10253 1/20 0.35
POLB P06746 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HCAR3 P49019 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29793698 0.90 WNK1 (0.41) WNK1HSD11B1TP53DHFRRXFP1
SCHEMBL10924129 0.85 MAPK1 (0.41) WNK1HSD11B1TP53DHFRALDH1A1
SCHEMBL3037513 0.85 KMT2A (0.40) WNK1ALDH1A1MEN1KMT2AMAPT
SCHEMBL3036505 0.85 KMT2A (0.47) HSD11B1TP53ALDH1A1KMT2AMAPT
SCHEMBL20240595 0.82 NPC1 (0.44) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL16782293 0.82 MAPT (0.41) WNK1HSD11B1DHFRALDH1A1MEN1
SCHEMBL5346439 0.82 ATM (0.42) WNK1HSD11B1TP53DHFRALDH1A1
SCHEMBL20520337 0.80 HPGD (0.39) WNK1HSD11B1TP53DHFRALDH1A1
SCHEMBL23092182 0.79 BCL6 (0.40) ALDH1A1CYP2D6MEN1KMT2AMAPT
SCHEMBL4095108 0.78 HTT (0.44) CYP2D6MEN1KMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119775277-A Compounds as modulators of LRRK2, NUAK1 and/or TYK2 kinases for the treatment of, for example, autoimmune diseases 原真股份有限公司 2025-04-08 CN disclosed
CN-114793435-B Compounds as modulators of LRRK2, NUAK1 and/or TYK2 kinases for the treatment of, for example, autoimmune diseases 原真股份有限公司 2024-10-01 CN disclosed
CN-115103844-A 1, 4-dihydrobenzo [ D ] pyrazolo [3,4-F ] [1,3] diazepine derivatives and related compounds as modulators of LRRK2, NUAK1 and/or TYK2 kinases for the treatment of e.g. autoimmune diseases 原真股份有限公司 2022-09-23 CN disclosed
CN-114793435-A 1, 4-dihydrobenzo [ D ] pyrazolo [3,4-F ] [1,3] diazepine derivatives and related compounds as modulators of LRRK2, NUAK1, and/or TYK2 kinases for the treatment of, for example, autoimmune diseases 原真股份有限公司 2022-07-26 CN disclosed